Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762125 · ClinicalTrials.gov registry record · Phase 2
Subgroups of Fibromyalgia Syndrome (FMS): Symptoms, Beliefs, and Tailored Treatment
A Phase 2 study of Fibromyalgia, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 266
- Enrollment target
- 1
- Study location
NCT00762125 is a Phase 2 study of Fibromyalgia that has completed, run by University of Washington. The registered enrollment target is 266 participants, above the 176-participant average among 76 other Fibromyalgia trials with a reported enrollment target (51% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00762125, a Phase 2 study of Fibromyalgia, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 266 participants
- Enrollment target
- 1
- Study location
Study Summary
Fibromyalgia syndrome (FMS) refers to a set of symptoms that include exhaustion, muscle pain, and tender points, where slight pressure can cause pain. Doctors do not know what causes FMS or how to cure it, but some treatments have helped relieve its symptoms. Progressive exercise, in which exercise is started at low levels and then increased, is one of the most reliable treatments, but people with FMS often avoid exercise or stop after completing exercise programs. This research will focus on the idea that people with FMS do not exercise because they are afraid of injury or have had a negative experience exercising. Participants will undergo one or a combination of several different treatments that aim to reduce fear of exercising. The different treatments will then be evaluated on their effectiveness in reducing disability among people with FMS.
Conditions Studied
Interventions
- BEHAVIORAL CR+ST
- BEHAVIORAL ET
- BEHAVIORAL AC treatment
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2005-12 |
| Est. Completion | 2012-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00762125
The ClinicalTrials.gov registry entry for NCT00762125 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 176-participant average among 76 other Fibromyalgia trials with a reported enrollment target (51% higher). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 3 interventions - of which CR+ST is the first listed.
NCT00762125 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00762125 about?
NCT00762125 is a clinical study titled "Subgroups of Fibromyalgia Syndrome (FMS): Symptoms, Beliefs, and Tailored Treatment". Fibromyalgia syndrome (FMS) refers to a set of symptoms that include exhaustion, muscle pain, and tender points, where slight pressure can cause pain. Doctors do not know what causes FMS or how to cure it, but some treatments have helped relieve its symptoms. Progressive exercise, in which exercise ...
What is the current status of trial NCT00762125?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 266 participants. The study started on 2005-12. Estimated completion is 2012-01.
What conditions does trial NCT00762125 study?
This clinical trial studies the following conditions: Fibromyalgia.
What interventions are being tested in trial NCT00762125?
The interventions under investigation include: CR+ST (BEHAVIORAL), ET (BEHAVIORAL), AC treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00762125?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00762125 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nitrous Oxide as Treatment for Fibromyalgia
RECRUITING · Phase 2
-
Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia
COMPLETED · Phase 2
-
Dextromethorphan in Fibromyalgia
COMPLETED · Phase 2
-
Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain
COMPLETED · Phase 2
-
Heart Rate Variability in Response to Metformin Challenge
COMPLETED · Phase 2
-
Gabapentin in Fibromyalgia Trial (GIFT)
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.